% | $
Quotes you view appear here for quick access.

Qiagen NV Message Board

  • wbart21 wbart21 Oct 8, 2007 2:48 PM Flag

    Digene admits inability

    to successfully maintain infringement litigation vs twti via interragatory per twti PR today.If twti in fact secures FTO in the HPV space with their broad spectrum and 16/18 genotype tests to be filed this Q with FDA they will be acquired in short order,imo.I'm watching Genprobe or Lab Corp and note that Roche bought NimbleGen and now currently subleases lab/office space from Third Wave so Roche is obviously well aware of their science.I know many of you were in Digene,twti at sub 400mm with unique HPV positioning presents a very interesting investment albeit unlikely to in any way duplicate Digene's success as the HPV first mover and monopolistic authority.I am biased because I have long owned twti,but you may want to look if interested in the space.

25.055+0.355(+1.44%)12:10 PMEDT